Congenital fibrosarcoma. Preoperative chemotherapy and conservative surgery

Cancer. 1986 Oct 1;58(7):1400-6. doi: 10.1002/1097-0142(19861001)58:7<1400::aid-cncr2820580703>3.0.co;2-q.

Abstract

Three cases of congenital fibrosarcoma are reported. The use of preoperative chemotherapy, a VAC regimen, allowed conservative surgery in two of them. The three children are well, with no evidence of disease and without sequelae after completion of postoperative chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Neoplasms / congenital*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / pathology
  • Bone Neoplasms / surgery
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Dactinomycin / administration & dosage
  • Female
  • Fibrosarcoma / congenital*
  • Fibrosarcoma / drug therapy
  • Fibrosarcoma / pathology
  • Fibrosarcoma / surgery
  • Humans
  • Infant, Newborn
  • Male
  • Ribs / surgery
  • Soft Tissue Neoplasms / congenital*
  • Soft Tissue Neoplasms / drug therapy
  • Soft Tissue Neoplasms / pathology
  • Soft Tissue Neoplasms / surgery
  • Vincristine / administration & dosage

Substances

  • Dactinomycin
  • Vincristine
  • Cyclophosphamide

Supplementary concepts

  • VAC protocol